- Additional Authors
- Center for Drug Evaluation and Research (U.S.)
- Description
- 27 pages : digital, PDF file
- Alternative Title
- Influenza, developing drugs for treatment and/or prophylaxis
- Subject
- Note
- Title from title screen (viewed on May 5, 2009).
- "Draft guidance."
- "February 2009."
- Bibliography (note)
- Includes bibliographical references (pages 26-27).
- System Details (note)
- Mode of access: Internet from the CDER web site. Address as of 5/5/09: http://www.fda.gov/cder/guidance/7927dft.pdf; current access available via PURL.
- Call Number
- GPO Internet HE 20.4702:IN 3/DRAFT
- OCLC
- marcive320245796
- Title
Guidance for industry : influenza, developing drugs for treatment and/or prophylaxis.
- Publisher
Silver Spring, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, [2009]
- Type of Content
text
- Type of Medium
computer
- Type of Carrier
online resource
- System Details
Mode of access: Internet from the CDER web site. Address as of 5/5/09: http://www.fda.gov/cder/guidance/7927dft.pdf; current access available via PURL.
- Bibliography
Includes bibliographical references (pages 26-27).
- Connect to:
- Added Author
Center for Drug Evaluation and Research (U.S.)
- Gpo Item No.
0499-T (online)
- Sudoc No.
HE 20.4702:IN 3/DRAFT